ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Efficacy of Low Dose Chemoprophylaxis for Coccidioidomycosis Infection in Liver Transplantation Recipients

    R. El Ramahi,2 S. Habib,1 S. Rosen,3 S. Farran,3 C. Walker,3 J. Shubeilat,4 S. Yost,5 O. McCotter,6 M. Cassal,6 A. Rana,7 T. Boyer,1 T. Zangeneh.2

    1Liver Research Institute, Divisions of Gastroenterology, Hepatology and Transplantation, Department of Medicine, University of Arizona, Tucson, AZ; 2Division of Infectious Disease, Department of Medicine, University of Arizona, Tucson, AZ; 3Internal Medicine Residency Program, Department of Medicine, University of Arizona, Tucson, AZ; 4Division of Infectious Disease, Department of Medicine, University of Massachusetts, Worcester, MA; 5Division of Transplantation, School of Pharmacy, University of Arizona, Tucson, AZ; 6Office of Border Health, Arizona Department of Health Services, Tucson, AZ; 7Division of Transplantation, Department of Surgery, University of Arizona, Tucson, AZ.

    Introduction:Coccidioidomycosis(CM) infection rate of 6.9% has been reported in solid organ transplantation recipients living in endemic Southwestern U.S.Aim:Assess the risk of CM infection in liver…
  • 2015 American Transplant Congress

    MicroRNAs in Kidney Graft Preservation Fluid as Novel Biomarkers for Delayed Graft Function

    L. Ooms, H. Roest, S. van den Hoek, R. de Bruin, J. IJzermans, L. van der Laan, F. Dor.

    Transplant Surgery, Erasmus Medical Center, Rotterdam, Netherlands.

    Introduction: Delayed graft function is a common complication after deceased donor kidney transplantation (KT), which affects both short and long-term outcome. Currently available biomarkers in…
  • 2015 American Transplant Congress

    Early Conversion to Everolimus in De Novo Kidney Transplant Recipients: 12-Month Results from the ELEVATE Study

    J. de Fijter, H. Holdaas, A. Speziale, G. Junge, Z. Wang, J. Cruzado, M. van der Giet.

    For the ELEVATE Study, Leiden, Netherlands.

    Purpose: Long-term exposure to calcineurin inhibitors (CNIs) contributes to unfavorable long-term outcomes, including inferior renal function and premature graft loss with vascular lesions, glomerulosclerosis and…
  • 2015 American Transplant Congress

    The Impact of the New Antivirals Sofosfuvir/Ledipasvir on Liver Transplantation for Hepatitis C Cirrhosis

    S. Munoz,1 D. Reich,2 K. Rothstein.1

    1Div of Hepatology, Liver Failure Unit, Hanemann University Hospital, Philadelphia, PA; 2Liver, Kidney and Pancreas Transplant Program, Hahnemann University Hospital, Philadelphia, PA.

    The approval of potent antiviral therapy (AVT) with sofosfuvir/ledipasvir (sof/ldv) for hepatitis C (HCV) dramatically increased cure rates (SVR) to nearly 100%. A recent prospective…
  • 2015 American Transplant Congress

    An Economic Analysis of Tolerance Induction for Two-Haplotype Match Kidney Living Donor Transplant Recipients

    K. Erickson,1 W. Winkelmayer,2 R. Lowsky,1 J. Scandling,1 S. Strober.1

    1Medicine, Stanford University, Palo Alto, CA; 2Medicine, Baylor College of Medicine, Houston, TX.

    Purpose:Tolerance induction is a novel therapy that enables some living donor kidney transplant recipients (LDKTR) to safely discontinue immunosuppressive (IS) therapy. We examine whether tolerance…
  • 2015 American Transplant Congress

    Inhibition of RhoA Pathway-Related Macrophage Functions Abrogates Chronic Rejection of Cardiac Allograft

    M. Kloc, J. You, N. Tejpal, X. Li, R. Ghobrial.

    TMHRI, Houston, TX.

    Objective. Chronic rejection remains the main obstacle in the long-term success of organ transplantation. The long-term survival of allografted hearts is limited by a progressive…
  • 2015 American Transplant Congress

    Real-Time Measurements of Tissue Oxygen Microtension as a Marker of Bile Duct Viability in Liver Transplantation

    R. Ciria-bru, E. Navarro-Rodriguez, M. Sanchez-Frías, J. Medina-Fernandez, A. Gallardo-Herrera, M. Ayllon-Teran, S. Rufián-Peña, P. Lopez-Cillero, J. Briceño-Delgado.

    General Surgery, HU Reina Sofía, Córdoba, Spain.

    Aims: To evaluate bile duct viability by assessing its microvascular quality using an innovative real-time oxygen tension device by testing different areas in both donor…
  • 2015 American Transplant Congress

    Propensity Score-Weighted Analysis of Induction Therapies in Live Donor Kidney Transplantation in Modern Immunosuppression Era

    B. Tanriover,1 S. Zhang,2 M. MacConmara.3

    1Medicine, UTSW, Dallas, TX; 2Clinical Sciences, UTSW, Dallas, TX; 3Surgery, UTSW, Dallas, TX.

    Background: Induction therapy with interleukin-2 receptor antagonist (IL2-RA) is recommended as a first line agent in living donor renal transplantation (LRT). However, use of IL2-RA…
  • 2015 American Transplant Congress

    Hybrid-Natural Orifice Transluminal Endoscopic Surgery (NOTES) for Laparoscopic Donor Nephrectomy Offers Better Postoperative Pain, Cosmesis and Surgical Outcomes Than Transumbilical Single Site Surgery

    M. Miura, H. Higashiyama.

    Department of Renal Transplantation Surgery, Sapporo Hokuyu Hospital, Sapporo, Japan.

    Objectives: Laparoendoscopic single site donor nephrectomy (LESSDN) via the umbilicus has been our standard care for living donors. Although we have previously reported better cosmetic…
  • 2015 American Transplant Congress

    Vaccine-Induced 'Incognito' CD8+ T Cell Memory Can Disrupt Transplantation Tolerance

    M. Nelsen,1 K. Beard,2 R. Kedl,1 R. Gill.2

    1Dept of Immunology & Microbiology, Univ of Colorado, Aurora, CO; 2Dept of Surgery, Univ of Colorado, Aurora, CO.

    Transplant recipients harbor immunity to vaccines and pathogens (e.g. CMV, EBV). Pre-existing immunity can have significant antigen-specific ramifications, usually attributed to heterologous immunity, as pathogen-reactive…
  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences